Recipharm’s revenue model praised by Swedish industry group

Recipharm has been awarded commended for its revenue model and “achievements and success beyond the norm” by industry group, SwedenBio.

The Jordbro, Sweden-headquartered contract development and manufacturing organisation (CDMO) was awarded a prize for its efforts at a ceremony last week where SwedenBio chairman, Lars Aldersson, predicted its approach would inspire others.

Recipharm shows that with the help of strong leadership, a responsible investment strategy and focus on quality it is possible to build a global life science company based in Sweden, something that will hopefully inspire others to similar deeds.”

SwedenBio’s citation stated that Recipharm “has purposefully and with great skill built a solid organisation with a critical mass” adding that “a good revenue model has contributed to that the company created jobs in Sweden, but also established itself internationally.”